SA
GSK icon

Strategic Advisors’s GSK GSK Stock Holding History

Strategic Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,000
Closed -$600K – 167
2019
Q2 		$600K Sell
12,000
-1,600
-12% -$80.3K 0.23% 85
2019
Q1 		$710K Sell
13,600
-6,400
-32% -$320K 0.27% 79
2018
Q4 		$955K Sell
20,000
-2,800
-12% -$138K 0.42% 63
2018
Q3 		$1.15M Buy
+22,800
New +$1.16M 0.42% 60
2017
Q4 		– Sell
-5,292
Closed -$269K – 138
2017
Q3 		$269K Sell
5,292
-666
-11% -$33.8K 0.12% 133
2017
Q2 		$321K Buy
5,958
+14
+0.2% +$746 0.15% 121
2017
Q1 		$313K Buy
+5,944
New +$302K 0.15% 115
2016
Q2 		– Sell
-40,967
Closed -$2.08M – 124
2016
Q1 		$2.08M Sell
40,967
-102
-0.2% -$5.08K 1.18% 26
2015
Q4 		$2.07M Sell
41,069
-1,835
-4% -$93.5K 1.36% 21
2015
Q3 		$2.06M Buy
42,904
+5,205
+14% +$271K 1.43% 21
2015
Q2 		$1.96M Buy
37,699
+6,495
+21% +$366K 1.25% 25
2015
Q1 		$2.09M Sell
31,204
-6,108
-16% -$350K 1.34% 20
2014
Q4 		$1.99M Hold
37,312
– – 1.3% 23
2014
Q3 		$2.14M Buy
37,312
+6,108
+20% +$374K 1.41% 22
2014
Q2 		$2.09M Buy
31,204
+513
+2% +$34.7K 1.33% 20
2014
Q1 		$2.05M Buy
30,691
+2,160
+8% +$146K 1.38% 20
2013
Q4 		$1.9M Sell
28,531
-1,185
-4% -$76.8K 1.3% 23
2013
Q3 		$1.86M Sell
29,716
-1,248
-4% -$80.3K 1.53% 20
2013
Q2 		$1.95M Buy
+30,964
New +$1.97M 1.74% 14

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Strategic Advisors's GSK Position: Q3 2019 in Review

Strategic Advisors sold out of GSK (GSK) in Q3 2019, closing a stake of 12,000 shares — an estimated $600K sold.

Strategic Advisors first reported a position in GSK in Q2 2013 and held it in 19 quarters. The position peaked at $2.14M in Q3 2014. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Strategic Advisors reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Strategic Advisors sold 12,000 GSK shares in Q3 2019, an estimated $600K.
  • Strategic Advisors first reported a position in GSK in Q2 2013 and held it in 19 quarters.
  • Strategic Advisors's GSK position peaked at $2.14M in Q3 2014.
  • 805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Strategic Advisors's 13F filing for Q3 2019, filed 17 Oct 2019.